[
    [
        {
            "time": "2021-01-06",
            "original_text": "万泰生物：鼻喷流感病毒载体新冠疫苗临床试验结果存在一定的不确定性",
            "features": {
                "keywords": [
                    "万泰生物",
                    "鼻喷流感病毒载体",
                    "新冠疫苗",
                    "临床试验",
                    "不确定性"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "万泰生物：鼻喷流感病毒载体新冠疫苗临床试验结果存在一定的不确定性",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-01-06",
            "original_text": "万泰生物龙虎榜数据",
            "features": {
                "keywords": [
                    "万泰生物",
                    "龙虎榜",
                    "交易数据"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "万泰生物龙虎榜数据",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-01-01",
            "original_text": "兴证医药行业2021年1月投资月报：创新药差异化、国际化时代开启",
            "features": {
                "keywords": [
                    "兴证医药",
                    "创新药",
                    "差异化",
                    "国际化",
                    "投资月报"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        }
    ]
]